Wednesday, August 14, 2024 11:35:06 AM
Recent CDT News
- Conduit Pharmaceuticals to Revolutionize Drug Development Through Agreement to Use Artificial Intelligence and Cybernetics • GlobeNewswire Inc. • 12/12/2024 12:30:00 PM
- Conduit Pharmaceuticals Receives Further Patent Approval For Lead Asset Targeting Autoimmune Disorders • GlobeNewswire Inc. • 11/21/2024 12:30:00 PM
- Conduit Pharmaceuticals Announces Appointment of Simon Fry to Board of Directors • GlobeNewswire Inc. • 11/19/2024 09:30:00 PM
- Conduit Pharmaceuticals Announces Debt Restructuring and Additional Notes • GlobeNewswire Inc. • 11/01/2024 08:45:00 PM
- Conduit Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference • GlobeNewswire Inc. • 08/28/2024 12:00:00 PM
- Conduit Pharmaceuticals Selects Initial Indications for Lead Clinical Candidate Targeting Autoimmune Disorders • GlobeNewswire Inc. • 08/12/2024 11:00:00 AM
- Conduit Pharmaceuticals Enters into Exclusive License Agreement with AstraZeneca for Multiple Assets to Advance Potential First-in-Class Treatments • GlobeNewswire Inc. • 08/08/2024 10:30:00 AM
- Conduit Pharmaceuticals Receives Patent Approval For Its Lead Asset Targeting Autoimmune Diseases • GlobeNewswire Inc. • 07/16/2024 11:30:00 AM
- Conduit Pharmaceuticals to Join Russell 3000® Index • GlobeNewswire Inc. • 06/13/2024 12:00:00 PM
- A Presidio Property Trust Major Investment To Be Part of Russell 2000® • GlobeNewswire Inc. • 05/29/2024 08:21:47 PM
- Conduit Pharmaceuticals Appoints Dr. Joanne Holland as Chief Scientific Officer • GlobeNewswire Inc. • 03/19/2024 11:00:00 AM
- Conduit Pharmaceuticals Announces Opening of Prime Laboratory Space in Europe’s Leading Life Sciences Hub • GlobeNewswire Inc. • 03/11/2024 11:00:00 AM
- Conduit Pharmaceuticals to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference • GlobeNewswire Inc. • 01/31/2024 01:30:00 PM
UAV Corp Skyborne Technology Secures $105M in Sales Contract LOIs for Revolutionary DART Series Airships • UMAV • Jan 13, 2025 11:00 AM
SANUWAVE Health Announces Preliminary Revenue Results for the Fourth Quarter 2024 (Ended December 31, 2024) • SNWV • Jan 13, 2025 8:10 AM
SANUWAVE Health Appoints Industry Veteran Timothy Wern as Executive Vice President of Sales • SNWV • Jan 13, 2025 8:08 AM
North Bay Resources Announces Operation of New Gravity Circuit at Bishop Gold Mill, California • NBRI • Jan 10, 2025 8:29 AM
Cannabix Technologies Announces Key Hardware Advancements to Marijuana Breathalyzer Technology • BLO • Jan 9, 2025 8:49 AM
UAV Corp. (UMAV) Further Reduces Authorized Shares to 500 Million • UMAV • Jan 8, 2025 2:27 PM